Skip to main content
Premium Trial:

Request an Annual Quote

Most Likely It'll Mean More Forms

The National Institutes of Health has been trying to crack down on conflicts of interest, to the point that some NIH researchers declined to give talks to industry, says blogger Derek Lowe at In the Pipeline. At the same time, Lowe points out, NIH is moving toward more translational science, which will mean more interactions with industry. "So how will the NIH manage that if the drug industry is seen as contaminating their Purity of Essence?" he asks.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.